Back

Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?

26 August 2018 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Lipid-lowering therapy beyond LDL Cholesterol Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

3 More presentations in this session

Presentation thumbnail
Lp(a): Is there any benefit from reducing it?
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Is it time to sing the requiem for HDL cholesterol?
Professor U. Laufs (Leipzig, DE)
Slides Video
Presentation thumbnail
Does LDL induce inflammation? If so, does it matter?
Professor J. Jukema (Leiden, NL)
Slides Video

Access the full session

Session thumbnail
Lipid-lowering therapy beyond LDL Cholesterol

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Welcome & introduction
29 August 2025
thumbnail
Congress Presentation
The influence of triglyceride and low-density-lipoprotein target levels on microcirculation
4 April 2025
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
3 April 2025
thumbnail
Congress Presentation
Triglyceride lowering after MI
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources